Shahdad Azmoon, MD

Original Contribution

Vascular Complications after Percutaneous Coronary Intervention Following Hemostasis (see full title below)

03/31/2010

Ramin Ebrahimi , MD;

Shahdad Azmoon , MD;

Craig Hjemdahl-Monsen , MD;

Joseph Vozzolo , MD;

Archana Rajdev , MD;

Kumar Kalapatapu , MD;

Wilbert S. Aronow , MD, AGSF;

Anthony L. Pucillo , MD;

Jae H. Ro , MD;

Vascular Complications after Percutaneous Coronary Intervention Following Hemostasis with the Mynx Vascular Closure Device Versus the AngioSeal Vascular Closure Device ABSTRACT: We investigated the prevalence of vascular complications after...

Vascular Complications after...

03/31/2010

Journal of Invasive Cardiology

Review

Effect of Preprocedural Statin Use on Procedural Myocardial
Infarction and Major Cardiac Adverse Events in Percutaneous
Corona

08/01/2008

Ramin Ebrahimi , MD;

Jahandar Saleh , MD;

Edward Toggart , MD;

Shahdad Azmoon , MD;

Hormoz Babaei , MD;

Ryan Smith , MD;

Stanley A. Rubin , MD;

James S. Lee , MD, DO;

Atman P. Shah , MD, FACC, FSCAI;

Mohammad Reza Movahed , MD, PhD, FACP, FACC, FSCAI;

Multiple primary and secondary prevention trials demonstrate a significant reduction in adverse cardiovascular outcomes in patients with, or at risk of, coronary artery disease as a result of statin therapy.1–6 Furthermore, there is...

Multiple primary and secondary...

08/01/2008

Journal of Invasive Cardiology